Literature DB >> 24817802

Quantitative Evaluation of Treatment Related Changes on Multi-Parametric MRI after Laser Interstitial Thermal Therapy of Prostate Cancer.

Satish Viswanath1, Robert Toth2, Mirabela Rusu1, Dan Sperling3, Herbert Lepor4, Jurgen Futterer5, Anant Madabhushi1.   

Abstract

Laser interstitial thermal therapy (LITT) has recently shown great promise as a treatment strategy for localized, focal, low-grade, organ-confined prostate cancer (CaP). Additionally, LITT is compatible with multi-parametric magnetic resonance imaging (MP-MRI) which in turn enables (1) high resolution, accurate localization of ablation zones on in vivo MP-MRI prior to LITT, and (2) real-time monitoring of temperature changes in vivo via MR thermometry during LITT. In spite of rapidly increasing interest in the use of LITT for treating low grade, focal CaP, very little is known about treatment-related changes following LITT. There is thus a clear need for studying post-LITT changes via MP-MRI and consequently to attempt to (1) quantitatively identify MP-MRI markers predictive of favorable treatment response and longer term patient outcome, and (2) identify which MP-MRI markers are most sensitive to post-LITT changes in the prostate. In this work, we present the first attempt at examining focal treatment-related changes on a per-voxel basis (high resolution) via quantitative evaluation of MR parameters pre- and post-LITT. A retrospective cohort of MP-MRI data comprising both pre- and post-LITT T2-weighted (T2w) and diffusion-weighted (DWI) acquisitions was considered, where DWI MRI yielded an Apparent Diffusion Co-efficient (ADC) map. A spatially constrained affine registration scheme was implemented to first bring T2w and ADC images into alignment within each of the pre- and post-LITT acquisitions, following which the pre- and post-LITT acquisitions were aligned. Pre- and post-LITT MR parameters (T2w intensity, ADC value) were then standardized to a uniform scale (to correct for intensity drift) and then quantified via the raw intensity values as well as via texture features derived from T2w MRI. In order to quantify imaging changes as a result of LITT, absolute differences were calculated between the normalized pre- and post-LITT MRI parameters. Quantitatively combining the ADC and T2w MRI parameters enabled construction of an integrated MP-MRI difference map that was highly indicative of changes specific to the LITT ablation zone. Preliminary quantitative comparison of the changes in different MR parameters indicated that T2w texture may be highly sensitive as well as specific in identifying changes within the ablation zone pre- and post-LITT. Visual evaluation of the differences in T2w texture features pre- and post-LITT also appeared to provide an indication of LITT-related effects such as edema. Our preliminary results thus indicate great potential for non-invasive MP-MRI imaging markers for determining focal treatment related changes, and hence long- and short-term patient outcome.

Entities:  

Keywords:  focal treatment; laser interstitial thermal therapy; multi-parametric MRI; prostate cancer; registration; treatment change

Year:  2013        PMID: 24817802      PMCID: PMC4013115          DOI: 10.1117/12.2008037

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN: 0277-786X


  25 in total

1.  Elastic registration of multimodal prostate MRI and histology via multiattribute combined mutual information.

Authors:  Jonathan Chappelow; B Nicolas Bloch; Neil Rofsky; Elizabeth Genega; Robert Lenkinski; William DeWolf; Anant Madabhushi
Journal:  Med Phys       Date:  2011-04       Impact factor: 4.071

2.  Prostate cancer characterization on MR images using fractal features.

Authors:  R Lopes; A Ayache; N Makni; P Puech; A Villers; S Mordon; N Betrouni
Journal:  Med Phys       Date:  2011-01       Impact factor: 4.071

3.  New variants of a method of MRI scale standardization.

Authors:  L G Nyúl; J K Udupa; X Zhang
Journal:  IEEE Trans Med Imaging       Date:  2000-02       Impact factor: 10.048

4.  Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 Tesla endorectal, in vivo T2-weighted MR imagery.

Authors:  Satish E Viswanath; Nicholas B Bloch; Jonathan C Chappelow; Robert Toth; Neil M Rofsky; Elizabeth M Genega; Robert E Lenkinski; Anant Madabhushi
Journal:  J Magn Reson Imaging       Date:  2012-02-15       Impact factor: 4.813

5.  Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens.

Authors:  Alphaeus M Wise; Thomas A Stamey; John E McNeal; John L Clayton
Journal:  Urology       Date:  2002-08       Impact factor: 2.649

6.  T2-Weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy.

Authors:  Antonio C Westphalen; John Kurhanewicz; Rui M G Cunha; I-Chow Hsu; John Kornak; Shoujun Zhao; Fergus V Coakley
Journal:  Int Braz J Urol       Date:  2009 Mar-Apr       Impact factor: 1.541

7.  Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study.

Authors:  Timothy R Nathan; Douglas E Whitelaw; Stanley C Chang; William R Lees; Paul M Ripley; Heather Payne; Linda Jones; M Constance Parkinson; Mark Emberton; Alison R Gillams; Anthony R Mundy; Stephen G Bown
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

8.  Image guided photothermal focal therapy for localized prostate cancer: phase I trial.

Authors:  U Lindner; R A Weersink; M A Haider; M R Gertner; S R H Davidson; M Atri; B C Wilson; A Fenster; J Trachtenberg
Journal:  J Urol       Date:  2009-08-14       Impact factor: 7.450

Review 9.  Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.

Authors:  Scott E Eggener; Peter T Scardino; Peter R Carroll; Michael J Zelefsky; Oliver Sartor; Hedvig Hricak; Thomas M Wheeler; Samson W Fine; John Trachtenberg; Mark A Rubin; Mak Ohori; Kentaro Kuroiwa; Michel Rossignol; Lucien Abenhaim
Journal:  J Urol       Date:  2007-10-15       Impact factor: 7.450

10.  Focal laser ablation of prostate cancer: definition, needs, and future.

Authors:  Pierre Colin; Serge Mordon; Pierre Nevoux; Mohammed Feras Marqa; Adil Ouzzane; Philippe Puech; Gregory Bozzini; Bertrand Leroux; Arnauld Villers; Nacim Betrouni
Journal:  Adv Urol       Date:  2012-05-16
View more
  4 in total

1.  Quantitative identification of magnetic resonance imaging features of prostate cancer response following laser ablation and radical prostatectomy.

Authors:  Geert J S Litjens; Henkjan J Huisman; Robin M Elliott; Natalie Nc Shih; Michael D Feldman; Satish Viswanath; Jurgen J Fütterer; Joyce G R Bomers; Anant Madabhushi
Journal:  J Med Imaging (Bellingham)       Date:  2014-10-27

Review 2.  The expanding landscape of diffusion-weighted MRI in prostate cancer.

Authors:  Andreas G Wibmer; Evis Sala; Hedvig Hricak; Hebert Alberto Vargas
Journal:  Abdom Radiol (NY)       Date:  2016-05

3.  Intravoxel Incoherent Motion Diffusion Weighted MR Imaging for Monitoring the Instantly Therapeutic Efficacy of Radiofrequency Ablation in Rabbit VX2 Tumors without Evident Links between Conventional Perfusion Weighted Images.

Authors:  Ziyi Guo; Qiang Zhang; Xiaoguang Li; Zhengyu Jing
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

4.  Noninvasive Dynamic Imaging of Tumor Early Response to Nanoparticle-mediated Photothermal Therapy.

Authors:  Fan Zhang; Jianbo Cao; Xiao Chen; Kai Yang; Lei Zhu; Guifeng Fu; Xinglu Huang; Xiaoyuan Chen
Journal:  Theranostics       Date:  2015-10-18       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.